Rule 8 - (Cambridge Antibody)
07 February 2003 - 11:01PM
UK Regulatory
RNS Number:2155H
JP Morgan Investment Management Inc
07 February 2003
FORM 8.1/8.3
Lodge with RNS (which will publicise and copy to the Panel).
Use separate form for each class of securities in which dealings have
been made.
Date of disclosure ......7th February 2003
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS
Date of dealing 6th February 2003
Dealing in Cambridge Antibody Technology Group Plc (name of company)
(1) Class of securities (eg ordinary shares) Ordinary Shares
(2)
Amount bought Amount Sold Price per unit
6,105 4.745 GBP
(3) Resultant total of the same class owned or controlled
(and percentage of class) ............................. 373,607 (1.03%)
(4) Party making disclosure J.P. Morgan Investment Management Inc
(5) EITHER (a) Name of purchaser/vendor (Note 1)
OR (b) If dealing for discretionary client(s), name of fund management
organisation
J.P. Morgan Investment Management Inc
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) NO
(ii) offeree company NO
Specify which category or categories of associate (1-8)
If category (8), explain
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
of the class of relevant securities dealt in) YES
Signed, for and on behalf of the party named in (4) above
(Also print name of signatory) Sara Moth
Telephone and extension number 020 7325 5808
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCEAFAXESNDEFE
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Oct 2023 to Oct 2024